Sort by
Refine Your Search
-
, including health insurance, retirement plans, paid time off, and professional development resources. Details are available at: https://postdocs.yale.edu/postdoc-benefits Application Submission: Application
-
A postdoctoral associate position is available in the laboratory of Dr. Mark Lee (https://medicine.yale.edu/profile/mark_n_lee/?tab=research ) at the Yale School of Medicine in New Haven
-
Title of the Position: Postdoctoral Associate Functional Genomics / Regulatory Genomics / Human Evolution & Disease Department and School: Department of Genetics, Yale School of Medicine Anticipated
-
colorectal cancer. The successful candidate will have the opportunity to lead metabolite identification and downstream translational analyses, while also developing independent research directions related
-
-driven mathematical modeling in a transdiagnostic clinical cohort. https://impact-mh.org/awardees/impact-mh/ IMPACT-Y is collecting repeated measures from approximately 2,400 individuals across multiple
-
–microbial interactions, and colorectal cancer. The successful candidate will have the opportunity to lead metabolite identification and downstream translational analyses, while also developing independent
-
, design and analysis of virus-derived RNA libraries, and development of machine learning models for detecting functional elements in viral metagenomic datasets. This project is a collaboration with the
-
Postdoctoral Associate | Mitochondrial Genomics | Lake Lab — Yale University, Department of Genetics
individuals and cell types, and define interactions between mitochondrial and nuclear genomes. Projects will involve developing and applying new technologies to measure mtDNA variation and dynamics, performing
-
are to understand fundamental biological mechanisms, develop biomarkers and novel therapeutic strategies to mitigate progressive kidney failure in native and allograft kidneys. Our well-funded research opportunities
-
on developing biofluid biomarkers that improve diagnosis, define disease heterogeneity, and can be implicated in clinical trials. A major complementary effort in the lab focuses on advanced